中文名称:MC-Val-Cit-PAB

中文别名:N-[6-(2,5-二氢-2,5-二氧代-1H-吡咯-1-基)-1-氧代己基]-L-缬氨酰-N5-(氨基甲酰基)-N-[4-(羟甲基)苯基]-L-鸟氨酰胺;N- [6-(2,5-二氢-2,5-二氧代-1H-吡咯-1-基)-1-氧代己基] -L-缬氨酰-N;MC-VAL-CIT-PAB中间体;MC-VAL-CIT-PAB-羟基;VCLINK;6-(2,5-二氧代-2,5-二氢-1-吡咯基)-N-[(S)-1-[[(S)-1-[[4-(羟甲基)苯基]氨基]-1-氧代-5-脲基-2-戊基]氨基]-3-甲基-1-氧代-2-丁基]己酰胺

英文名称:MC-Val-Cit-PAB

英文别名:MC-Val-it-PAB;N-[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-6-(2,5-dioxopyrrol-1-yl)hexanamide;N-[6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide;L-OrnithinaMide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aMinocarbonyl)-N-[4-(hydroxyMethyl)phenyl]-;6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide;ML-Val-Cit-PAB;MC-Val-Cit-PAB, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-;MC-Val-Cit-PAB

CAS:159857-80-4

EINECS:-

分子式:C28H40N6O7

分子量:572.65

分子结构:

危险标志:-

风险术语:-

安全术语:-

物化性质:-

熔点:-

相对密度:1.276

溶解性:-

用途:

MC-Val-Cit-PAB中间体用作试剂用于制备抗体-药物偶联物，这是一种选择性地将细胞毒性药物传递到肿瘤相关抗原的化合物。

上游原料:6-(马来酰亚胺基)己酸琥珀酰亚胺酯,对氨基苯甲醇,VAL-CIT-PAB,6-Maleimidocaproic acid-PFP ester,CIT-PAB,6-马来酰亚胺基己酸,Fmoc-L-缬氨酸,L-瓜氨酸,(S)-2 - ((S)-2 - (((((9H-芴-9-基)甲氧基)羰基)氨基)-3-甲基丁酰氨基,FMOC-VAL-OSU,Fmoc-Val-Cit-PAB,6-氨基己酸

下游产品:马来酰亚胺基己酰-L-缬氨酸-L-瓜氨酸对氨基苄醇 对硝基苯基碳酸脂